ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 54 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 208.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $62,000 | +37.8% | 36,600 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | -13.5% | 36,600 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | -38.8% | 36,600 | -48.2% | 0.00% | – |
| Q2 2020 | $85,000 | +107.3% | 70,600 | +104.6% | 0.00% | – |
| Q1 2020 | $41,000 | -8.9% | 34,500 | +61.2% | 0.00% | – |
| Q4 2019 | $45,000 | -4.3% | 21,400 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | -13.0% | 21,400 | 0.0% | 0.00% | – |
| Q2 2019 | $54,000 | -1.8% | 21,400 | +50.7% | 0.00% | – |
| Q1 2015 | $55,000 | +14.6% | 14,200 | +97.2% | 0.00% | – |
| Q4 2014 | $48,000 | -35.1% | 7,200 | -46.3% | 0.00% | – |
| Q3 2014 | $74,000 | -46.0% | 13,400 | 0.0% | 0.00% | – |
| Q2 2014 | $137,000 | – | 13,400 | +60809.1% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 22 | -97.3% | 0.00% | – |
| Q4 2013 | $9,000 | -96.2% | 822 | -96.3% | 0.00% | – |
| Q3 2013 | $239,000 | +8.1% | 22,222 | -6.6% | 0.00% | – |
| Q2 2013 | $221,000 | – | 23,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |